Nucleic acid detection kit for detecting BRCA1mRNA (breast cancel susceptibility gene1 messenger ribonucleic acid)
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 杭州艾迪康医学检验中心有限公司
- Publication Date
- 2013-12-18
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of life science and biotechnology, in particular to a gene detection kit, which can detect the expression level of BRCA1 in human breast cancer by using probe real-time fluorescent quantitative PCR technology, which can effectively save detection time and improve detection precision. Background technique
[0002] Breast cancer is a common tumor in women and has become the second leading cause of cancer death. Its diagnosis is mainly based on imaging examinations, lacking laboratory-specific diagnostic indicators, which brings difficulties to early diagnosis and is easy to be missed or misdiagnosed. Surgical resection is the first choice for the treatment of breast cancer, but the shape is affected after surgery, and the appearance is not good. It has caused great distress to patients, and some patients have psychological shadows caused by it, which seriously affects their quality of life. At present, it is generally...